Performance of Bleeding Risk Scores in Predicting Bleeding Complications in Korean Patients Who Are Receiving Dual Antiplatelet Therapy for Acute Coronary Syndrome
Authors:
- Pil Sang SongPSPil Sang Song
- Kye Taek AhnKAKye Taek Ahn
- Jae-Hyeong ParkJPJae-Hyeong Park
- Do-Yoon KangDKDo-Yoon Kang
- Duk-Woo ParkDPDuk-Woo Park
- Si Wan ChoiSCSi Wan Choi
- 1 February 2022
- journal article
- editorial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 165, 131-132
Abstract
No abstract availableFunding Information
- Chungnam National University Hospital
This publication has 6 references indexed in Scilit:
- Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive ManagementCirculation, 2019
- External Validation of the ORBIT Bleeding Score and the HAS-BLED Score in Nonvalvular Atrial Fibrillation Patients Using Direct Oral Anticoagulants (Asian Data from the DIRECT Registry)The American Journal of Cardiology, 2019
- Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trialsThe Lancet, 2017
- Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting StentsJACC, 2016
- World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCINature Reviews Cardiology, 2014
- Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trialEuropean Heart Journal, 2009